Android app on Google Play

Unusual 11 Mid-Day Movers 02/12: (STEM) (AVP) (ZIOP) Higher; (LVLT) (CLSN) (KVHI) Lower

February 12, 2013 1:01 PM EST Send to a Friend
Get Alerts STEM Hot Sheet
Trade STEM Now!
Join SI Premium – FREE
StemCells, Inc. (Nasdaq: STEM) 24.6% HIGHER; announced that the twelve-month data from the first patient cohort in the Company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate (purified human neural stem cells) for chronic spinal cord injury continued to demonstrate a favorable safety profile, and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted. The third patient remains stable.

Avon Products, Inc. (NYSE: AVP) 20.0% HIGHER; reported Q4 adjusted EPS of $0.37, $0.10 better than the analyst estimate of $0.27. Revenue for the quarter came in at $2.96 billion versus the consensus estimate of $3 billion.

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) 19.3% HIGHER; announced that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS.

Old Second Bancorp Inc. (Nasdaq: OSBC) 18.8% HIGHER; Dimensional Fund Advisors disclosed a lower stake of 937,558, or about 6.7 percent of total outstanding.

Albany Molecular Research (Nasdaq: AMRI) 18.4% HIGHER; reported Q4 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for the quarter came in at $59.1 million versus the consensus estimate of $56.49 million. Sees FY2013 EPS of $0.34-$0.52, versus the consensus of $0.24. Sees contract revenue growth between 8% and 12%.

Level 3 Communications, Inc. (NYSE: LVLT) 10.9% LOWER; reported Q4 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.6 billion.

Celsoion (Nasdaq: CLSN) 10.8% LOWER; lower amid a couple negative blog posts made earlier in the day.

KVH Industries, Inc. (Nasdaq: KVHI) 10.7% LOWER; reported Q4 EPS of $0.18, $0.02 better than the analyst estimate of $0.16. Revenue for the quarter came in at $39.5 million versus the consensus estimate of $37.62 million.

Qualys (Nasdaq: QLYS) 10.3% LOWER; reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.46 million. Sees Q1 2013 EPS of ($0.01)-$0.01, versus the consensus of $0.04. Qualys sees Q1 2013 revenue of $24.4-$24.9 million, versus the consensus of $25.34 million. Sees FY2013 EPS of $0.16-$0.20, versus the consensus of $0.17. Qualys sees FY2013 revenue of $106-$108 million, versus the consensus of $108.56 million.

MELA Sciences, Inc. (Nasdaq: MELA) 9.5% LOWER; announced the pricing of an underwritten offering of 6,100,000 shares of its common stock at an offering price of $1.30 per share.

To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.




You May Also Be Interested In


Related Categories

Special Reports

Related Entities

Unusual 11 Mid-Day Movers

Add Your Comment